Abstract

BackgroundHyper IgE recurrent infection syndrome (HIES) is a rare immune deficiency, characterized by recurrent staphylococcal skin and lung abscesses, pneumonia and increased IgE levels. The majority of autosomal dominant HIES (AD HIGE) is due to hypomorphic mutations in the signal transducer and the activator of transcription 3 (STAT3) gene.Case presentationFive patients were diagnosed with HIES, based on the clinical criteria and scoring system developed at the National Institutes of Health (NIH), USA. The STAT3 gene was sequenced and previously described mutations were identified in all five patients. We compare the clinical features of our patients with those from Asia, Europe and the US.ConclusionEven though the number of patients is limited, there are some clinical differences in patients from South Asia compared to European and even East Asian patients. However, the mutations detected are located at hot spots seen in western and Asian patients with AD HIGE.

Highlights

  • Hyper IgE recurrent infection syndrome (HIES) is a rare immune deficiency, characterized by recurrent staphylococcal skin and lung abscesses, pneumonia and increased IgE levels

  • The mutations detected are located at hot spots seen in western and Asian patients with AD HIGE

  • We report 5 cases of AD HIGE from Sri Lanka that were identified using clinical criteria and the scoring system developed at the National Institutes of Health, USA [15]

Read more

Summary

Conclusion

The mortality rate seems to be higher in South Asia compared to East Asia and the West and recurrent pneumonia is less common in the sub-continent. The mutations detected are located at the same hot spots seen in Western and East Asian AD HIGE patients. Less advanced health care facilities in South Asia may be responsible for the worse outcomes in this regions. All authors read and approved the final manuscript. Author details 1 Medical Research Institute, Colombo, Sri Lanka. 2 Lady Ridgeway Hospital, Colombo, Sri Lanka. 4 Institute of Infection and Immunity, Royal Free Hospital, London, UK

Background
Findings
Discussion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call